Selected research
Industry Research
Monocyte Activation Test Industry Research Report 2026
Market perspective
The global Monocyte Activation Test market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Monocyte Activation Test market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Monocyte Activation Test market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Monocyte Activation Test market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Monocyte Activation Test include Thermo Fisher Scientific, Landfar, Merck KGaA, Mindray, SOLVIAS AG, Microcoat Biotechnologie GmbH, Lonza Group, Charles River Laboratories International, Inc. and Becton, Dickinson and Company. among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Monocyte Activation Test market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Monocyte Activation Test.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Monocyte Activation Test Market by Company
Thermo Fisher Scientific
Landfar
Merck KGaA
Mindray
SOLVIAS AG
Microcoat Biotechnologie GmbH
Lonza Group
Charles River Laboratories International, Inc.
Becton, Dickinson and Company
Monocyte Activation Test Segment by Type
MAT Kits
Reagents
Monocyte Activation Test Segment by Application
Biotechnology Industry
Medical Device Industry
Pharmaceutical Industry
Others
Monocyte Activation Test Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Monocyte Activation Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Monocyte Activation Test and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Monocyte Activation Test.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Monocyte Activation Test companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- MAT Kits
- Reagents
Applications
- Biotechnology Industry
- Medical Device Industry
- Pharmaceutical Industry
- Others
Companies covered
- Thermo Fisher Scientific
- Landfar
- Merck KGaA
- Mindray
- SOLVIAS AG
- Microcoat Biotechnologie GmbH
- Lonza Group
- Charles River Laboratories International, Inc.
- Becton, Dickinson and Company
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Monocyte Activation Test by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 MAT Kits
- 2.2.3 Reagents
- 2.3 Monocyte Activation Test by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Biotechnology Industry
- 2.3.3 Medical Device Industry
- 2.3.4 Pharmaceutical Industry
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Monocyte Activation Test Breakdown Data by Type
- 3.1 Global Monocyte Activation Test Historic Market Size by Type (2021-2026)
- 3.2 Global Monocyte Activation Test Forecasted Market Size by Type (2027-2032)
4 Monocyte Activation Test Breakdown Data by Application
- 4.1 Global Monocyte Activation Test Historic Market Size by Application (2021-2026)
- 4.2 Global Monocyte Activation Test Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Monocyte Activation Test Market Perspective (2021-2032)
- 5.2 Global Monocyte Activation Test Growth Trends by Region
- 5.2.1 Global Monocyte Activation Test Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Monocyte Activation Test Historic Market Size by Region (2021-2026)
- 5.2.3 Monocyte Activation Test Forecasted Market Size by Region (2027-2032)
- 5.3 Monocyte Activation Test Market Dynamics
- 5.3.1 Monocyte Activation Test Industry Trends
- 5.3.2 Monocyte Activation Test Market Drivers
- 5.3.3 Monocyte Activation Test Market Challenges
- 5.3.4 Monocyte Activation Test Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Monocyte Activation Test Players by Revenue
- 6.1.1 Global Top Monocyte Activation Test Players by Revenue (2021-2026)
- 6.1.2 Global Monocyte Activation Test Revenue Market Share by Players (2021-2026)
- 6.2 Global Monocyte Activation Test Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Monocyte Activation Test Head Office and Area Served
- 6.4 Global Monocyte Activation Test Players, Product Type & Application
- 6.5 Global Monocyte Activation Test Manufacturers Established Date
- 6.6 Global Monocyte Activation Test Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Monocyte Activation Test Market Size (2021-2032)
- 7.2 North America Monocyte Activation Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Monocyte Activation Test Market Size by Country (2021-2026)
- 7.4 North America Monocyte Activation Test Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Monocyte Activation Test Market Size (2021-2032)
- 8.2 Europe Monocyte Activation Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Monocyte Activation Test Market Size by Country (2021-2026)
- 8.4 Europe Monocyte Activation Test Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Monocyte Activation Test Market Size (2021-2032)
- 9.2 Asia-Pacific Monocyte Activation Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Monocyte Activation Test Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Monocyte Activation Test Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Monocyte Activation Test Market Size (2021-2032)
- 10.2 South America Monocyte Activation Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Monocyte Activation Test Market Size by Country (2021-2026)
- 10.4 South America Monocyte Activation Test Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Monocyte Activation Test Market Size (2021-2032)
- 11.2 Middle East & Africa Monocyte Activation Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Monocyte Activation Test Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Monocyte Activation Test Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Thermo Fisher Scientific
- 12.1.1 Thermo Fisher Scientific Company Information
- 12.1.2 Thermo Fisher Scientific Business Overview
- 12.1.3 Thermo Fisher Scientific Revenue in Monocyte Activation Test Business (2021-2026)
- 12.1.4 Thermo Fisher Scientific Monocyte Activation Test Product Portfolio
- 12.1.5 Thermo Fisher Scientific Recent Developments
- 12.2 Landfar
- 12.2.1 Landfar Company Information
- 12.2.2 Landfar Business Overview
- 12.2.3 Landfar Revenue in Monocyte Activation Test Business (2021-2026)
- 12.2.4 Landfar Monocyte Activation Test Product Portfolio
- 12.2.5 Landfar Recent Developments
- 12.3 Merck KGaA
- 12.3.1 Merck KGaA Company Information
- 12.3.2 Merck KGaA Business Overview
- 12.3.3 Merck KGaA Revenue in Monocyte Activation Test Business (2021-2026)
- 12.3.4 Merck KGaA Monocyte Activation Test Product Portfolio
- 12.3.5 Merck KGaA Recent Developments
- 12.4 Mindray
- 12.4.1 Mindray Company Information
- 12.4.2 Mindray Business Overview
- 12.4.3 Mindray Revenue in Monocyte Activation Test Business (2021-2026)
- 12.4.4 Mindray Monocyte Activation Test Product Portfolio
- 12.4.5 Mindray Recent Developments
- 12.5 SOLVIAS AG
- 12.5.1 SOLVIAS AG Company Information
- 12.5.2 SOLVIAS AG Business Overview
- 12.5.3 SOLVIAS AG Revenue in Monocyte Activation Test Business (2021-2026)
- 12.5.4 SOLVIAS AG Monocyte Activation Test Product Portfolio
- 12.5.5 SOLVIAS AG Recent Developments
- 12.6 Microcoat Biotechnologie GmbH
- 12.6.1 Microcoat Biotechnologie GmbH Company Information
- 12.6.2 Microcoat Biotechnologie GmbH Business Overview
- 12.6.3 Microcoat Biotechnologie GmbH Revenue in Monocyte Activation Test Business (2021-2026)
- 12.6.4 Microcoat Biotechnologie GmbH Monocyte Activation Test Product Portfolio
- 12.6.5 Microcoat Biotechnologie GmbH Recent Developments
- 12.7 Lonza Group
- 12.7.1 Lonza Group Company Information
- 12.7.2 Lonza Group Business Overview
- 12.7.3 Lonza Group Revenue in Monocyte Activation Test Business (2021-2026)
- 12.7.4 Lonza Group Monocyte Activation Test Product Portfolio
- 12.7.5 Lonza Group Recent Developments
- 12.8 Charles River Laboratories International, Inc.
- 12.8.1 Charles River Laboratories International, Inc. Company Information
- 12.8.2 Charles River Laboratories International, Inc. Business Overview
- 12.8.3 Charles River Laboratories International, Inc. Revenue in Monocyte Activation Test Business (2021-2026)
- 12.8.4 Charles River Laboratories International, Inc. Monocyte Activation Test Product Portfolio
- 12.8.5 Charles River Laboratories International, Inc. Recent Developments
- 12.9 Becton, Dickinson and Company
- 12.9.1 Becton, Dickinson and Company Company Information
- 12.9.2 Becton, Dickinson and Company Business Overview
- 12.9.3 Becton, Dickinson and Company Revenue in Monocyte Activation Test Business (2021-2026)
- 12.9.4 Becton, Dickinson and Company Monocyte Activation Test Product Portfolio
- 12.9.5 Becton, Dickinson and Company Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst